StockTipsArenaBeta

Eris Lifesciences Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,121.2-15.10 (-1.33%)

Avg 1-year target

All 5 long-term calls are BUY

₹1,681.450.0% above today's price

Eris Lifesciences' average 1-year share price target is ₹1,681.4, the average of 5 advisors' latest targets. Targets range from ₹1,471 to ₹1,800.

Latest: Elara Capital ₹1,471 · 28 Aug 2026

5
5 BUY · 0 SELL, all horizons
5
with an active 1Y target
64%
7 of 11 closed calls hit
16
all horizons, open and closed
Watch ERIS for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Eris Lifesciences target price by brokerage

Each advisor's latest 1-year target · 5 advisors · tap a row for the call

All tips (16)

BUYTarget₹1,471
ECbyElara Capital+31.2% to target
1 Year* · 10 mo left · 28 Aug 2026 · entry ₹1,310 · via ET Now (Live)P&L -14.4%
BUYTarget₹1,730
HSbyHDFC Securities+54.3% to target
1 Year* · 9 mo left · 29 Jul 2026 · entry ₹1,427 · via Economic Times New Stock RecosP&L -21.4%
BUYTarget₹1,650
SJbySandeep Jain, Tradeswift+47.2% to target
1 Year · 9 mo left · 16 Jul 2026 · entry ₹1,438 · via Zee Business (Live)P&L -22.0%
BUYTarget₹1,800
PLbyPrabhudas Lilladher+60.5% to target
1 Year* · 4 mo left · 16 Feb 2026 · entry ₹1,364.4 · via Institutional / Brokerage ResearchP&L -17.8%
BUYTarget₹1,756
BCbyBOB Capital Markets+56.6% to target
1 Year* · 4 mo left · 15 Feb 2026 · entry ₹1,414.4 · via Institutional / Brokerage ResearchP&L -20.7%
BUYTarget₹1,740
PLbyPrabhudas LilladherTarget hit
1 Year* · 20 May 2025 · entry ₹1,470.2 · via Institutional / Brokerage Researchexit ₹1,740
BUYTarget₹1,450
PLbyPrabhudas LilladherTarget hit
1 Year* · 5 Feb 2025 · entry ₹1,390.2 · via Institutional / Brokerage Researchexit ₹1,450
BUYTarget₹1,418
BCbyBOB Capital MarketsTarget hit
1 Year* · 5 Feb 2025 · entry ₹1,390.2 · via Institutional / Brokerage Researchexit ₹1,418
BUYTarget₹1,648
BCbyBOB Capital MarketsTarget hit
1 Year* · 26 Oct 2024 · entry ₹1,274.35 · via Institutional / Brokerage Researchexit ₹1,648
BUYTarget₹1,200
BCbyBOB Capital MarketsTarget hit
1 Year* · 22 May 2024 · entry ₹907.7 · via Institutional / Brokerage Researchexit ₹1,200
BUYTarget₹1,100
PLbyPrabhudas LilladherTarget hit
1 Year* · 14 Feb 2024 · entry ₹865.55 · via Institutional / Brokerage Researchexit ₹1,100
BUYTarget₹1,975
PLbyPrabhudas LilladherExpired
1 Year* · 6 Aug 2025 · entry ₹1,724.8 · via Institutional / Brokerage Researchexit ₹1,375.1
BUYTarget₹1,609
VbyVenturaExpired
1 Year* · 23 Feb 2024 · entry ₹875.5 · via Institutional / Brokerage Researchexit ₹1,279.15
BUYTarget₹1,750
PLbyPrabhudas LilladherExpired
1–3 Months* · 9 Jul 2026 · entry ₹1,416 · via Economic Times New Stock Recosexit ₹1,155.1
BUYTarget₹1,360
PMbyPawan MaheshwariTarget hit
1–2 Weeks* · 8 Sept 2026 · entry ₹1,320.3 · via CNBC Awaaz.exit ₹1,360
BUYTarget₹1,430
SJbySandeep Jain, TradeswiftExpired
1–2 Weeks* · 7 Sept 2026 · entry ₹1,327.4 · via Zee Business (Live)exit ₹1,291.1

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks